Navigation Links
Fish Oil Supplements Don't Protect Against Heart Trouble: Study
Date:5/9/2013

By Steven Reinberg
HealthDay Reporter

WEDNESDAY, May 8 (HealthDay News) -- Although previous research has shown that omega-3 fatty acids may help those who have already had a heart attack or suffer from heart failure, a new study finds that the supplements do little to prevent cardiac trouble in people who have risk factors for heart disease.

Italian researchers reported that omega-3 fatty acid supplements did not reduce death from heart disease or heart attacks or strokes in this vulnerable group.

"Contrary to the expectations, adding supplemental omega-3 fatty acids does not have any specific advantage in a population that is considered at high risk of cardiovascular disease," said lead researcher Dr. Gianni Tognoni, from the Istituto di Ricerche Farmacologiche in Milan.

Tognoni said omega-3 fatty acids do seem to help prevent abnormal heart rhythms following a heart attack or heart failure. There appears, however, to be no value in taking the supplements to prevent heart disease, he added.

"Don't trust too much on drugs that attempt to mimic lifestyle [changes]," Tognoni said.

It's the usual recommendations that really ward off heart disease, he said, including not smoking, eating a healthy diet and getting exercise.

Study co-author Dr. Maria Carla Roncaglioni, head of the Laboratory of General Practice Research at the Istituto di Ricerche Farmacologiche Mario Negri, added that "there is no need to add a long-term preventive treatment with omega-3 fatty acids in people with cardiovascular risk factors [that are controlled with] evidence-based treatments and healthy lifestyle -- particularly with regard to dietary habits."

The report was published in the May 9 issue of the New England Journal of Medicine.

One expert said the evidence on omega-3 fatty acids has been mixed.

"Some prior clinical trials have shown a beneficial effect of omega-3 fatty acids derived from fish -- also known as fish oil or n-3 polyunsaturated fatty acids -- in patients with established cardiovascular disease or to prevent cardiovascular events in the general adult population," said Dr. Gregg Fonarow, a professor of cardiology at the University of California, Los Angeles. "However, other clinical trials have shown no benefit."

"Based on the totality of current evidence, the pendulum appears to be shifting away from omega-3 fatty acid supplementation providing significant cardiovascular event reduction," Fonarow said.

To see if omega-3 fatty acids had a beneficial effect, the Italian researchers randomly assigned more than 12,000 people who had risk factors for heart disease to either omega-3 fatty acid supplements or a placebo.

During five years of follow-up, more than 1,400 people died from heart disease or had a heart attack or stroke, the researchers found. Among those taking omega-3 fatty acid supplements, 11.7 percent had one of these outcomes, compared to 11.9 percent of those taking a placebo.

More information

For more on heart disease, visit the American Heart Association.

SOURCES: Gianni Tognoni, M.D., Istituto di Ricerche Farmacologiche, Milan; Maria Carla Roncaglioni, head, Laboratory of General Practice Research, Istituto di Ricerche Farmacologiche, Milan; Gregg Fonarow, M.D., professor, cardiology, University of California, Los Angeles; March 9, 2013, New England Journal of Medicine


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Omega-3 Supplements No Help Against Repeat Heart Trouble: Review
2. Fish Oil Supplements Wont Help in Multiple Sclerosis: Study
3. Supplements and cancer prevention: A cautionary tale
4. Dietary supplements increase cancer risk
5. Body Building, Diet Supplements Linked to Liver Damage: Study
6. Omega-3 Supplements May Not Aid Aging Brain
7. True-Dose to Exhibit Liquid Pet Supplements at the Cardinal Health Retail Business Conference in Orlando, FL on July 11-14
8. SupplementsToWeightLoss LLC (DBA: PharmaCo Labs) and also Classe Wines LLC announced that they have signed a 5 years lease on a warehouse
9. Iron supplements can reduce fatigue in nonanemic women
10. Study questions value of calcium and vitamin D supplements
11. Calcium, Vitamin D Supplements May Pose Risks for Men With Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Fish Oil Supplements Don't Protect Against Heart Trouble: Study
(Date:12/2/2016)... , ... December 02, 2016 , ... ... veterinarian diagnostic imaging systems and the first company to offer robotic imaging ... Heart at their tradeshow booth # 941 for the American Association of Equine ...
(Date:12/2/2016)... ... 2016 , ... Rijuven Corp launches rejiva ( http://www.rejiva.com ), a unique wearable ... wearable health technology on the market can deliver all that rejiva can. , “Rejiva ... about their health than the usual heart rate and steps taken”, adds Evens Augustin, ...
(Date:12/2/2016)... ... December 02, 2016 , ... "Pro3rd Accents Volume 2 is a ... versatile lower third titles with just a few clicks of the mouse," said Christina ... 30 lower third animations. Choose from various styles with accented animations, rigid boxes, simplistic ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... hot meals to needy individuals and families from eight different sites throughout Miami-Dade ... Thanksgiving Day. Over 1,000 volunteers worked very hard on Thanksgiving morning by putting ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... Technologist/Clinical Laboratory Scientist & Author of Type 2 Diabetes: The Owner’s Manual, ... The Sharon Kleyne Hour Power of Water, Global Climate Change and Your Health ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... Allergan plc (NYSE: AGN ), a ... previously announced Accelerated Share Repurchase (ASR) Program. Logo - ... ... previously announced, the Company entered into a variable tenor ASR ... repurchase $10 billion of its ordinary shares. Approximately 40.5 million ...
(Date:11/30/2016)... 2016 Research and Markets has ... Neuromodulation, Neurovascular, Neurosurgical and Monitoring Devices 2017 - MedView" ... ... The full report suite on the U.S. market for neurological ... intracranial pressure monitoring devices, detachable coils, liquid embolics, catheters, guidewires, ...
(Date:11/30/2016)... 2016 Varian Medical Systems (NYSE: ... JUST Company in the Healthcare Equipment and Services industry, ... inaugural "JUST 100 List." The rankings are based on ... conducted on attitudes towards corporate behavior, involving 50,000 Americans ... U.S companies against their peers within 32 major industries. ...
Breaking Medicine Technology: